REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
08/04/2025
Back to search
Official data from USPTO
TRAINED THERAPEUTIX DISCOVERY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TRAINED THERAPEUTIX DISCOVERY
ST13
US500000088017750Class
5, 10, 42
Filing
88017750
Registration
6115798
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/05/2025
Trademark type
Word
Nice classes
5, 10, 42
Filing date
06/27/2018
Registration date
08/04/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/04/2020
Last transaction
08/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Luxembourg, LU
Examiner
KEATING,SHANNON B
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Boulle, Ltd.
Representatives
Dyan M. House BAKER & MCKENZIE, LLP
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for ophthalmological use; pharmaceutical products for cardiovascular use; pharmaceutical preparations in the field of ophthalmology; pharmaceutical preparations in the field of cardiology; pharmaceuticals in the field of ophthalmology; pharmaceuticals in the field of cardiology; pharmaceutical preparationsa drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents
Class 10
Medical and surgical apparatus for use in general surgery; medical devices for the treatment of ophthalmological diseases and conditions; medical devices for the treatment of cardiovascular diseases and conditions; drug delivery systems
Class 42
Pharmaceutical research and development; pharmaceutical drug development services; consulting services in the field of pharmaceuticals and biotechnology research and development; conducting research and clinical trials relating to medical devices and pharmaceuticals in the field of ophthalmology; conducting research and clinical trials relating to medical devices and pharmaceuticals in the field of cardiology; development of pharmaceutical preparations and medicines; testing of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/04/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/19/2020
PUBO
PUBLISHED FOR OPPOSITION
05/19/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/29/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/30/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/30/2020
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/26/2020
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
09/26/2019
GNSI
INQUIRY TO SUSPENSION E-MAILED
09/26/2019
CNSI
SUSPENSION INQUIRY WRITTEN
09/26/2019
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
09/25/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/19/2019
GNSL
LETTER OF SUSPENSION E-MAILED
03/19/2019
CNSL
SUSPENSION LETTER WRITTEN
03/19/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/04/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/04/2019
ALIE
ASSIGNED TO LIE
03/04/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/27/2018
GNRT
NON-FINAL ACTION E-MAILED
08/27/2018
CNRT
NON-FINAL ACTION WRITTEN
08/27/2018
DOCK
ASSIGNED TO EXAMINER
08/13/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2018
NWAP
NEW APPLICATION ENTERED
06/30/2018
Continuous trademark protection
Get notified about every new filing that threatens TRAINED THERAPEUTIX DISCOVERY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.